VU-0155041 | m-entrepreneurship.com

Product Name :
VU-0155041

Search keywords :
VU0155041

drugId :
null

Target Vo:
Metabotropic glutamate receptor 4

Target Vo Short Name :
mGluR4

Moa_Name:
Metabotropic glutamate receptor 4 modulators

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Vanderbilt University

Active Company_Name :

Active Indication_Name:

In Active Indication_Name:
Parkinson Disease

Termination Status :
Preclinical

China Termination Status :

Highest Status:
Pending

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
Phospho-ERK1/2 (Tyr204/Tyr187) Rabbit pAb Epigenetic Reader Domain
Myc-tag Mouse mAb Epigenetics
DLAT Antibody (YA912): DLAT Antibody (YA912) is an unconjugated, approximately 69 kDa, mouse-derived, anti-DLAT (YA912) monoclonal antibody. DLAT Antibody (YA912) can be used for: WB, ICC/IF, IP expriments in human, mouse background without labeling.

Author: Betaine hydrochloride

Related Posts